Literature DB >> 23157292

Telomerase RNA biosynthesis and processing.

E M Smekalova1, O S Shubernetskaya, M I Zvereva, E V Gromenko, M P Rubtsova, O A Dontsova.   

Abstract

Telomerase synthesizes repetitive G-rich sequences (telomeric repeats) at the ends of eukaryotic chromosomes. This mechanism maintains the integrity of the genome, as telomere shortening leads to degradation and fusion of chromosomes. The core components of telomerase are the telomerase catalytic subunit and telomerase RNA, which possesses a small template region serving for the synthesis of a telomeric repeat. Mutations in the telomerase RNA are associated with some cases of aplastic anemia and also cause dyskeratosis congenita, myelodysplasia, and pulmonary fibrosis. Telomerase is active in 85% of cancers, and telomerase activation is one of the first steps in cell transformation. The study of telomerase and pathways where this enzyme is involved will help to understand the mechanism of the mentioned diseases and to develop new approaches for their treatment. In this review we describe the modern conception of telomerase RNA biosynthesis, processing, and functioning in the three most studied systems - yeast, vertebrates, and ciliates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23157292     DOI: 10.1134/S0006297912100045

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  19 in total

Review 1.  TERT Promoter Mutations in Thyroid Cancer.

Authors:  Ali S Alzahrani; Rawan Alsaadi; Avaniyapuram Kannan Murugan; Bakr Bin Sadiq
Journal:  Horm Cancer       Date:  2016-02-22       Impact factor: 3.869

2.  BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.

Authors:  Mingzhao Xing; Rengyun Liu; Xiaoli Liu; Avaniyapuram Kannan Murugan; Guangwu Zhu; Martha A Zeiger; Sara Pai; Justin Bishop
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

3.  Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma.

Authors:  Xiaoli Liu; Guojun Wu; Yuan Shan; Christian Hartmann; Andreas von Deimling; Mingzhao Xing
Journal:  Cell Cycle       Date:  2013-04-19       Impact factor: 4.534

4.  Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy.

Authors:  Rengyun Liu; Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2014-08-13       Impact factor: 5.678

5.  Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.

Authors:  Xiaoguang Shi; Rengyun Liu; Shen Qu; Guangwu Zhu; Justin Bishop; Xiaoli Liu; Hui Sun; Zhongyan Shan; Enhua Wang; Yahong Luo; Xianghong Yang; Jiajun Zhao; Jianling Du; Adel K El-Naggar; Weiping Teng; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2015-01-13       Impact factor: 5.958

6.  TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.

Authors:  Xiaoli Liu; Shen Qu; Rengyun Liu; Chunjun Sheng; Xiaoguang Shi; Guangwu Zhu; Avaniyapuram Kannan Murugan; Haixia Guan; Hongyu Yu; Yangang Wang; Hui Sun; Zhongyan Shan; Weiping Teng; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2014-03-11       Impact factor: 5.958

7.  TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma.

Authors:  Eun Ji Oh; Sohee Lee; Ja Seong Bae; Yourha Kim; Sora Jeon; Chan Kwon Jung
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

8.  Highly prevalent TERT promoter mutations in aggressive thyroid cancers.

Authors:  Xiaoli Liu; Justin Bishop; Yuan Shan; Sara Pai; Dingxie Liu; Avaniyapuram Kannan Murugan; Hui Sun; Adel K El-Naggar; Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2013-07-12       Impact factor: 5.678

9.  Low frequency of TERT promoter mutations in a series of well-differentiated follicular-patterned thyroid neoplasms.

Authors:  A Proietti; C Sartori; E Macerola; N Borrelli; G Materazzi; P Vitti; F Basolo
Journal:  Virchows Arch       Date:  2017-10-03       Impact factor: 4.064

10.  Prospective Analysis of TERT Promoter Mutations in Papillary Thyroid Carcinoma at a Single Institution.

Authors:  Yun-Suk Choi; Seong-Woon Choi; Jin-Wook Yi
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.